Advertisement

Topics

Asahi Kasei Pharma Corp. Company Profile

02:54 EST 20th January 2017 | BioPortfolio

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients throughout the world. www.akpamerica.com


News Articles [1391 Associated News Articles listed on BioPortfolio]

Basilea licenses isavuconazole to Asahi Kasei in Japan

Swiss drugmaker Basilea Pharmaceutica has entered into a partnering agreement with Asahi Kasei Pharma…

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei Corporation, T...

BRIEF-Evotec and Asahi Kasei Pharma enter drug discovery collaboration

* Entered into an integrated drug discovery collaboration with Asahi Kasei Pharma Corporation Source text for Eikon: Further company coverage:

Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Asahi Kasei Pharma Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Basilea licensed Asahi Kasei Pharma rights to isavuconazole in Japan

Basilea Pharmaceutica International Ltd. licensed Asahi Kasei Pharma Corp. exclusive rights to develop and commercialize the antifungal drug isavuconazole in Japan.

Asahi Kasei Corporation Strategy, SWOT and Corporate Finance Report Prices from USD $175

SummaryAsahi Kasei Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy...

Basilea, Asahi Kasei Pharma deal

Drugs and Medications [239 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

A Review of "Big Pharma, Women, and the Labour of Love"by Thea Cacchioni. Toronto, Canada: University of Toronto Press, 2015, 167 pages, $50.00 (hardcover), $21.95 (paperback), $20.85 (Kindle).

Anterior corpectomy versus posterior laminoplasty for the treatment of multilevel cervical myelopathy: A meta-analysis.

To compare the effectiveness between anterior corpectomy (CORP) and posterior laminoplasty (LAMP) for the treatment of multilevel cervical myelopathy.

▼Pitolisant for narcolepsy.

▼Pitolisant (Wakix-Bioprojet Pharma) is a new treatment for adults with narcolepsy with or without cataplexy. It was licensed for use in the EU in March last year and has orphan drug status.(1) Here...

Cognitive disorders in stroke patients: the possibilities of pharma-cological correction.

To determine the efficacy and safety of cellex in treatment of cognitive disorders in acute ischemic stroke (IS).

An overview of the China Bioanalytical Forum: interview with Daniel Tang.

Daniel Tang talks to Sankeetha Nadarajah, Commissioning Editor-(Bioanalysis), regarding the China Bioanalysis Forum (CBF), in which Daniel was one of the co-founders and remains as its co-chair. Danie...

Clinical Trials [72 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of Asahi ViE Dialyzer in Canada

The purpose of the study is to obtain performance data on the Asahi ViE-21 dialyzer (ViE-21) .

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Companies [700 Associated Companies listed on BioPortfolio]

Asahi Kasei Pharma Corp.

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Pharma America

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Corporation

Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, con...

Sankyo Kasei Co., Ltd.

Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 millionCapital increase: ¥50 million Sodium hydrosulfide plant completed (Akitsu Plant) ...

Rakuto Kasei Ltd

Rakuto Kasei(Israel) Ltd. was established in 1990 as a joint venture with Rakuto Kasei Industrial Co. Japan, a leading worldwide producer of enzymes. Based on over 20 years of experience in the field ...

More Information about "Asahi Kasei Pharma Corp." on BioPortfolio

We have published hundreds of Asahi Kasei Pharma Corp. news stories on BioPortfolio along with dozens of Asahi Kasei Pharma Corp. Clinical Trials and PubMed Articles about Asahi Kasei Pharma Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Asahi Kasei Pharma Corp. Companies in our database. You can also find out about relevant Asahi Kasei Pharma Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record